SAN DIEGO and VANCOUVER, British Columbia, Jan. 30, 2017 /PRNewswire/ -- Sophiris Bio Inc. (NASDAQ: SPHS) a biopharmaceutical company developing topsalysin (PRX302) for the treatment of urological diseases, today announced that Randall E. Woods, president and chief executive officer, will present a corporate overview at the BetterInvesting™ Virtual Investor Conference. The presentation will take place on Thursday February 2, 2017 at 1:00 p.m. Eastern Time.
The presentation will be webcast live at http://tinyurl.com/0202prepr and can also be accessed through the Investor Relations page at www.sophiris.com. A replay of the presentation will be available on the Company's website for 90 days.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.